Two concurrent mechanisms are responsible for the INa increase produced by dapagliflozin and empagliflozin in healthy and heart failure cardiomyocytes. - Rapún J; Pérez-Martín S; Cámara-Checa A; San José G; Núñez-Fernández R; Crespo-García T; Hoban A; Rubio-Alarcón M; Martínez-Blanco E; Tamargo J; Díez-Guerra FJ; López B; et al. (Biomedicine & Pharmacotherapy, 2025)